Sub Heading

Clinical Trials Details

Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

IRB Protocol Number
20210081

Clinical Trial Categories

  • Colorectal Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: 

  • Participants must have pathologically documented metastatic colorectal adenocarcinoma with central confirmation of KRAS p.G12C mutation.
  • Participants must have the ability to take oral medications and be willing to record daily adherence to investigational medication.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.